Identification and characterization of cancer mutations in Japanese lung adenocarcinoma without sequencing of normal tissue counterparts
about
The DDBJ Japanese Genotype-phenotype Archive for genetic and phenotypic human dataRegulation and function of P-Rex family Rac-GEFsMutational landscapes of tongue carcinoma reveal recurrent mutations in genes of therapeutic and prognostic relevance.DBTSS as an integrative platform for transcriptome, epigenome and genome sequence variation data.Routine genetic testing of lung cancer specimens derived from surgery, bronchoscopy and fluid aspiration by next generation sequencing.Epidermal growth factor receptor (EGFR) signaling regulates global metabolic pathways in EGFR-mutated lung adenocarcinoma.Therapeutic priority of the PI3K/AKT/mTOR pathway in small cell lung cancers as revealed by a comprehensive genomic analysis.Distinct allelic expression patterns of imprinted IGF2 in adenocarcinoma and squamous cell carcinoma of the lung.Aberrant transcriptional regulations in cancers: genome, transcriptome and epigenome analysis of lung adenocarcinoma cell lines.Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma.Receptor tyrosine kinase amplification is predictive of distant metastasis in patients with oral squamous cell carcinoma.Whole genome sequencing analysis of lung adenocarcinoma in Xuanwei, China.Treatment of lung adenocarcinoma by molecular-targeted therapy and immunotherapy.TMC-SNPdb: an Indian germline variant database derived from whole exome sequencesSequencing and phasing cancer mutations in lung cancers using a long-read portable sequencer.DBTSS/DBKERO for integrated analysis of transcriptional regulation.
P2860
Q24426218-E8616FD1-2576-4B16-8566-9BB3B2AAC9BDQ28087472-879452F7-6C7B-482E-833D-792D4B555E12Q30665308-F07F794A-9695-418C-A0AC-C206B84E060BQ30868314-DD5E8714-E9F3-4436-BA6D-D9AA64AEBD30Q33599057-9AD268F1-98F8-40CE-80A5-C3E15903B2DDQ33947130-F78DF61E-49D6-47DF-B277-E8AD5112F19DQ34134584-6D77C13A-C697-426D-8212-FB0B4D124491Q34427314-72E5D9EA-EFEF-495D-866D-8CAB51ECF288Q34712122-A03DDABE-D852-441A-AABF-5476D4407204Q35837200-6415FC3B-D6A5-4437-8166-DB418BBADF86Q37670693-8581A3D3-8DEF-4B81-BE46-14AC2A4871AFQ37677860-937819CF-241D-4E5B-9C39-D5495EE778C5Q39172334-633317A4-604C-4010-9919-D01CDF79C34DQ39611652-9332EEF8-EF0D-4428-8C11-C6E05CC5369BQ47134008-CEA10D2F-090D-4051-A783-82C0CCFC1339Q47160144-5E5B4BCA-05B2-4083-BBD0-2904B182D26E
P2860
Identification and characterization of cancer mutations in Japanese lung adenocarcinoma without sequencing of normal tissue counterparts
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Identification and characteriz ...... of normal tissue counterparts
@ast
Identification and characteriz ...... of normal tissue counterparts
@en
type
label
Identification and characteriz ...... of normal tissue counterparts
@ast
Identification and characteriz ...... of normal tissue counterparts
@en
prefLabel
Identification and characteriz ...... of normal tissue counterparts
@ast
Identification and characteriz ...... of normal tissue counterparts
@en
P2093
P2860
P1433
P1476
Identification and characteriz ...... of normal tissue counterparts
@en
P2093
Akikazu Kawase
Ayako Suzuki
Hiroyasu Esumi
Katsuya Tsuchihara
Koichi Goto
Koutatsu Matsushima
Makito Suzuki
Sachiyo Mimaki
Sumio Sugano
Yuki Yamane
P2860
P304
P356
10.1371/JOURNAL.PONE.0073484
P407
P577
2013-09-12T00:00:00Z